8-K: American Healthcare REIT Board Responds to Unsolicited Mini-Tender Offer, Remains Neutral

American Healthcare REIT's board has responded to an unsolicited mini-tender offer from Comrit Investments, remaining neutral and advising shareholders to carefully consider the offer.

Summary

• American Healthcare REIT (AHR) received an unsolicited mini-tender offer from Comrit Investments 1, Limited Partnership to purchase up to 228,136 shares of Class T and Class I common stock at $13.15 per share.
• The AHR board has decided to remain neutral on the offer and is not making any recommendation to shareholders.
• The offer price of $13.15 per share is equivalent to $3.29 per share before a one-for-four reverse stock split in November 2022.
• This offer price is approximately 58% lower than the board's most recent estimated net asset value (NAV) of $31.40 per share as of December 31, 2022.
• AHR had previously filed a registration statement for a potential public offering and NYSE listing, but there is no guarantee of when or if this will occur.
• The AHR share repurchase plan was suspended on November 14, 2022, which may create a need for liquidity for some shareholders.
• Secondary market trades of AHR common stock have been reported between $14.36 and $15.25 per share between September 19, 2023 and December 19, 2023.
• Shareholders who tender their shares will lose their right to receive any future distributions, which are currently at an annualized rate of $1.00 per share.
• Comrit acknowledges that its offer price was established based on its own analysis and objectives without consideration of the financial objectives of AHR shareholders.

Sentiment

Score: 3

Explanation: The document highlights a low-ball offer and the lack of liquidity options for shareholders, creating a negative sentiment.

Positives

• The board is providing shareholders with information about the offer and its potential implications.
• The board is highlighting the difference between the offer price and the estimated NAV.
• The board is informing shareholders of alternative options for liquidity, such as secondary market trades.

Negatives

• The mini-tender offer price is significantly below the estimated NAV.
• The AHR share repurchase plan is currently suspended.
• There is no guarantee of a public offering or other liquidity event.
• Tendering shareholders will lose future distributions.

Risks

• The mini-tender offer may be an opportunistic attempt by Comrit to profit at the expense of AHR shareholders.
• There is uncertainty regarding the timing and success of a potential public offering.
• Shareholders may need liquidity due to the suspension of the share repurchase plan.
• The value of AHR common stock is dependent on a number of factors and there is no certainty regarding its long-term value.

Future Outlook

The company is considering a potential public offering and NYSE listing, but there is no guarantee of when or if this will occur. The company also notes that there is no certainty regarding the long-term value of AHR's common stock.

Management Comments

• The Board MAKES NO RECOMMENDATION with respect to the Comrit tender offer.
• The Board believes that the Comrit Offer represents an opportunistic attempt by Comrit to purchase the Shares and make a profit.
• The Board understands that you must make your own independent decision whether to tender or refrain from tendering your shares.

Industry Context

Mini-tender offers are often used by third parties to acquire shares at below-market prices, and the SEC has issued warnings about these types of offers. This situation highlights the challenges faced by shareholders in illiquid markets.

Comparison to Industry Standards

• The 58% discount between the offer price and the estimated NAV is significant and suggests that the offer is not in line with the company's perceived value.
• The lack of a public market for AHR shares makes it difficult to compare the offer price to industry benchmarks.
• The suspension of the share repurchase plan is not uncommon for companies preparing for a potential public offering, but it does create liquidity challenges for shareholders.

Stakeholder Impact

• Shareholders are impacted by the unsolicited mini-tender offer and the potential loss of future distributions if they tender their shares.
• The company's management and board are impacted by the need to respond to the offer and provide guidance to shareholders.

Next Steps

• Shareholders are advised to carefully consider the Comrit Offer and consult with their financial advisors.
• Shareholders are encouraged to review AHR's SEC filings and the Comrit Offer documents.

Key Dates

Keywords

mini-tender offer, American Healthcare REIT, Comrit Investments, share repurchase, net asset value, public offering, liquidity, distributions, secondary market